Kissei Pharmaceutical Co (TSE:4547) Days Sales Outstanding : 123.59 (As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

What is Kissei Pharmaceutical Co Days Sales Outstanding?

Kissei Pharmaceutical Co's average Accounts Receivable for the three months ended in Dec. 2023 was 円28,283 Mil. Kissei Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was 円20,881 Mil. Hence, Kissei Pharmaceutical Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 123.59.

The historical rank and industry rank for Kissei Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

TSE:4547' s Days Sales Outstanding Range Over the Past 10 Years
Min: 112.39 Med: 125.08 Max: 140.94
Current: 126.62

During the past 13 years, Kissei Pharmaceutical Co's highest Days Sales Outstanding was 140.94. The lowest was 112.39. And the median was 125.08.

TSE:4547's Days Sales Outstanding is ranked worse than
84.52% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 72.57 vs TSE:4547: 126.62

Kissei Pharmaceutical Co's Days Sales Outstanding increased from Dec. 2022 (120.38) to Dec. 2023 (123.59).

Kissei Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Kissei Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kissei Pharmaceutical Co Days Sales Outstanding Chart

Kissei Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

133.96

112.39

125.65

119.08

120.43

Kissei Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															141.58	110.40	133.57	123.59	147.51

Competitive Comparison of Kissei Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kissei Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Kissei Pharmaceutical Co's Days Sales Outstanding falls into.

Kissei Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Kissei Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (22083	+	27790)	/	2 )	/	75579	*	365
=	24936.5					/	75579	*	365
=	120.43

Kissei Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (27064	+	29501)	/	2 )	/	20881	*	365 / 4
=	28282.5					/	20881	*	365 / 4
=	123.59

Kissei Pharmaceutical Co (TSE:4547) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Kissei Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Kissei Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Kissei Pharmaceutical Co (TSE:4547) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kissei Pharmaceutical Co Ltd (TSE:4547) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

KSPHF:USA

Address

19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710

Website

http://www.kissei.co.jp

Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kissei Pharmaceutical Co (TSE:4547) Headlines

No Headlines